Workflow
Rapid Micro Biosystems(RPID)
icon
Search documents
Rapid Micro Biosystems(RPID) - 2023 Q4 - Annual Report
2024-03-01 21:38
Table of Contents FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-40592 Rapid Micro Biosystems, Inc. (Exact name of Registrant as specified in its Charter) Delaware 20-8121647 (State or other jurisdiction of incorporation or organization) (I.R.S. Emplo ...
Rapid Micro Biosystems(RPID) - 2023 Q4 - Earnings Call Transcript
2024-03-01 18:31
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2023 Earnings Conference Call March 1, 2024 8:30 AM ET Company Participants Michael Beaulieu - CFA Vice President, Investor Relations and Corporate Communications Robert Spignesi - President and CEO Sean Wirtjes - Chief Financial Officer Conference Call Participants Daniel Arias - Stifel Steven Mah - TD Cowen Operator Ladies and gentlemen, thank you for standing by. My name is Desiree [ph], and I will be your conference operator today. At this time, I would like ...
Samsung Biologics 選擇 Rapid Micro Biosystems 的 Growth Direct® 平台以自動化關鍵微生物品質控制測試
GlobeNewswire Inc.· 2024-01-04 14:18
兩間公司共同致力創新品質控制流程,以應對規模、數據完整性和加快上市時間等生物製造挑戰羅威爾,麻薩諸塞州, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID)(以下簡稱「公司」)是一間創新生命科學技術公司,提供關鍵任務自動化解決方案,以促進醫療保健產品的高效生產和快速、安全發布。該公司今日宣布 Samsung Biologics (KRX: 207940.KS) 選擇了 Growth Direct® 平台來自動化其微生物品質控制流程,以提高效率、更穩健的數據完整性和可擴展的品質控制操作。 Rapid Micro Biosystems 董事長兼行政總裁 Robert Spignesi 表示:「Samsung Biologics 作為全球領先的合約開發和製造組織 (CDMO),展示了對生物製藥生產自動化和品質管理的堅定承諾。」「Growth Direct® 提高了品質控制微生物實驗室的營運效率和數據完整性,我們很榮幸能與 Samsung Biologics 合作。」 很多全球製藥商依靠 Growth Direct ...
Rapid Micro Biosystems(RPID) - 2023 Q3 - Quarterly Report
2023-11-03 20:16
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________ FORM 10-Q ________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission File N ...
Rapid Micro Biosystems(RPID) - 2023 Q3 - Earnings Call Transcript
2023-11-03 19:10
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2023 Earnings Call Transcript November 3, 2023 8:30 AM ET Company Participants Michael Beaulieu - Vice President of Investor Relations Robert Spignesi - CEO, President and Director Sean Wirtjes - Chief Financial Officer Conference Call Participants Daniel Arias - Stifel Steven Mah - TD Cowen Operator Thank you for holding, and welcome, everyone, to the Rapid Micro Biosystems' Third Quarter 2023 Earnings Call. All lines have been placed on mute to prevent any bac ...
Rapid Micro Biosystems(RPID) - 2023 Q2 - Quarterly Report
2023-08-04 20:32
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________ FORM 10-Q ________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission File Number ...
Rapid Micro Biosystems(RPID) - 2023 Q2 - Earnings Call Transcript
2023-08-04 18:24
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q2 2023 Earnings Call Transcript August 4, 2023 8:30 AM ET Company Participants Mike Beaulieu - Vice President of Investor Relations Rob Spignesi - CEO, President and Director Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Dan Arias - Stifel Operator Ladies and gentlemen, thank you for standing by, and welcome to Rapid Micro Biosystems' Q2 2023 Earnings Call. [Operator Instructions] I would now like to turn the confere ...
Rapid Micro Biosystems(RPID) - 2023 Q1 - Quarterly Report
2023-05-09 21:28
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________ FORM 10-Q ________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission File Numbe ...
Rapid Micro Biosystems(RPID) - 2023 Q1 - Earnings Call Transcript
2023-05-06 01:03
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q1 2023 Earnings Conference Call May 5, 2023 8:30 AM ET Company Participants Mike Beaulieu - Investor Relations Rob Spignesi - President and Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Operator Good morning, and welcome to the Rapid Micro Biosystems First Quarter Financial Results Call. All lines have been placed on mute to prevent any background noise. [Operator Instructions] And finally, I ...
Rapid Micro Biosystems(RPID) - 2022 Q4 - Annual Report
2023-03-10 22:30
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-40592 Rapid Micro Biosystems, Inc. (Exact name of Registrant as specified in its Charter) Delaware 20-8121647 (Sta ...